Advertisement

Journal of Bone and Mineral Metabolism

, Volume 37, Issue 1, pp 134–141 | Cite as

Gender differences in anti-osteoporosis drug treatment after osteoporotic fractures

  • Youn Jung
  • Yeonhee Ko
  • Ha Young Kim
  • Yong Chan Ha
  • Young-Kyun Lee
  • Tae-Young Kim
  • Dong-soo Choo
  • Sunmee JangEmail author
Original Article

Abstract

This study examined differences between men and women in factors affecting anti-osteoporosis drug treatment after osteoporotic fracture. Using a national claims database, we analyzed patients aged 50 years and older who experienced their first osteoporotic fracture between January 1, 2008, and December 31, 2012. We examined whether patients were prescribed anti-osteoporosis drugs within 6 months post-fracture. Factors associated with treatment status were identified using multivariate logistic regression. Among a total of 556,410 patients aged 50 and older, only 37% were prescribed anti-osteoporosis drugs within 6 months post-fracture. Female patients with fractures were more likely to receive pharmacotherapy than male patients (41.7 vs. 19.3%). Older age significantly increased the likelihood of receiving anti-osteoporosis drugs after osteoporotic fracture. For men, the adjusted odds ratio for receiving therapy was greatest in those aged 80 years and older (OR 6.4), and for women, it was largest in those aged 70–79 (OR 3.33). Both men and women were more likely to be prescribed drugs after a spine fracture, with men having significantly greater odds of receiving drug therapy (men, OR 7.1, 95% CI 6.5–7.9; women 4.79, CI 4.63–4.96). Patients with rheumatic disease or other osteoporosis-inducing comorbid disease were more likely to be prescribed anti-osteoporosis drugs. Our findings indicate that a lack of anti-osteoporosis pharmacotherapy after fracture remains a problem in Korea, especially among men, highlighting the need for effective quality improvement interventions to maximize post-fracture treatment rates.

Keywords

Fractures Gender differences Pharmacotherapy Post-fracture treatment Osteoporosis 

Notes

Acknowledgements

The National Health Insurance Database was made available by the National Health Insurance Service (NHIS) of Korea (NHIS-2017-4-054). The authors would like to thank the NHIS for its cooperation. This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Korea (grant number HI13C1522).

Compliance with ethical standards

Conflict of Interest

All authors have no conflicts of interest.

References

  1. 1.
    Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289CrossRefGoogle Scholar
  2. 2.
    Johnell O, Kanis JA (2004) An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 15:897–902.  https://doi.org/10.1007/s00198-004-1627-0 CrossRefGoogle Scholar
  3. 3.
    Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733.  https://doi.org/10.1007/s00198-006-0172-4 CrossRefGoogle Scholar
  4. 4.
    Ha YC, Kim TY, Lee A, Lee YK, Kim HY, Kim JH, Park CM, Jang S (2016) Current trends and future projections of hip fracture in South Korea using nationwide claims data. Osteoporos Int 27:2603–2609.  https://doi.org/10.1007/s00198-016-3576-9 CrossRefGoogle Scholar
  5. 5.
    Klop C, Gibson-Smith D, Elders PJ, Welsing PM, Leufkens HG, Harvey NC, Bijlsma JW, van Staa TP, de Vries F (2015) Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010. Osteoporos Int.  https://doi.org/10.1007/s00198-015-3098-x Google Scholar
  6. 6.
    Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382.  https://doi.org/10.1016/j.bone.2004.03.024 CrossRefGoogle Scholar
  7. 7.
    Klotzbuecher CM, Ross PD, Landsman PB, Berger M, Berger M, Abbott TA (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721CrossRefGoogle Scholar
  8. 8.
    von Friesendorff M, Besjakov J, Åkesson K (2008) Long-term survival and fracture risk after hip fracture: a 22-year follow-up in women. J Bone Miner Res 23:1832–1841CrossRefGoogle Scholar
  9. 9.
    Warriner AH, Patkar NM, Yun H, Delzell E (2011) Minor, major, low-trauma, and high-trauma fractures: what are the subsequent fracture risks and how do they vary? Current Osteoporos Rep 9:122–128CrossRefGoogle Scholar
  10. 10.
    Elliot-Gibson V, Bogoch E, Jamal S, Beaton D (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778CrossRefGoogle Scholar
  11. 11.
    Leslie W, Giangregorio L, Yogendran M, Azimaee M, Morin S, Metge C, Caetano P, Lix L (2012) A population-based analysis of the post-fracture care gap 1996–2008: the situation is not improving. Osteoporos Int 23:1623–1629CrossRefGoogle Scholar
  12. 12.
    Panneman MJ, Lips P, Sen SS, Herings RM (2004) Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int 15:120–124CrossRefGoogle Scholar
  13. 13.
    Shepherd A, Cass A, Ray L, Tan A, Wilkinson G (2012) Treatment for older men with fractures. Osteoporos Int 23:1041–1051CrossRefGoogle Scholar
  14. 14.
    Kim KH, Lee K, Ko YJ, Kim SJ, Oh SI, Durrance DY, Yoo D, Park SM (2012) Prevalence, awareness, and treatment of osteoporosis among Korean women: the Fourth Korea National Health and Nutrition Examination Survey. Bone 50:1039–1047.  https://doi.org/10.1016/j.bone.2012.02.007 CrossRefGoogle Scholar
  15. 15.
    Kim HY, Jang EJ, Park B, Kim TY, Shin SA, Ha YC, Jang S (2016) Development of a Korean Fracture Risk Score (KFRS) for predicting osteoporotic fracture risk: analysis of data from the Korean National Health Insurance Service. PLoS One 11:e0158918.  https://doi.org/10.1371/journal.pone.0158918 CrossRefGoogle Scholar
  16. 16.
    Skedros JG, Holyoak JD, Pitts TC (2006) Knowledge and opinions of orthopaedic surgeons concerning medical evaluation and treatment of patients with osteoporotic fracture. J Bone Joint Surg Am 88:18–24Google Scholar
  17. 17.
    Cadarette SM, Katz JN, Brookhart MA, Levin R, Stedman MR, Choudhry NK, Solomon DH (2008) Trends in drug prescribing for osteoporosis after hip fracture, 1995–2004. J Rheumatol 35:319–326Google Scholar
  18. 18.
    Roerholt C, Eiken P, Abrahamsen B (2009) Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int 20:299–307CrossRefGoogle Scholar
  19. 19.
    Solomon DH, Morris C, Cheng H, Cabral D, Katz JN, Finkelstein JS, Avorn J (2005) Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. In: Mayo Clinic Proceedings. Elsevier, vol 2, p 194–202Google Scholar
  20. 20.
    Jaglal SB, Carroll J, Hawker G, McIsaac WJ, Jaakkimainen L, Cadarette SM, Cameron C, Davis D (2003) How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs. Can Fam Physician 49:462–468Google Scholar
  21. 21.
    Alswat K, Adler SM (2012) Gender differences in osteoporosis screening: retrospective analysis. Arch Osteoporos 7:311–313.  https://doi.org/10.1007/s11657-012-0113-0 CrossRefGoogle Scholar
  22. 22.
    Ha YC, Lee YK, Lim YT, Jang SM, Shin CS (2014) Physicians’ attitudes to contemporary issues on osteoporosis management in Korea. J Bone Metab 21:143–149.  https://doi.org/10.11005/jbm.2014.21.2.143 CrossRefGoogle Scholar
  23. 23.
    Kiebzak G, Beinart G, Perser K, Ambrose C, Siff S, Heggeness M (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162:2217–2222CrossRefGoogle Scholar
  24. 24.
    Kim Y, Kim JH, Cho DS (2015) Gender difference in osteoporosis prevalence, awareness and treatment: based on the Korea national health and nutrition examination survey 2008–2011. J Korean Acad Nurs 45:293–305.  https://doi.org/10.4040/jkan.2015.45.2.293 CrossRefGoogle Scholar
  25. 25.
    Johnson CS, McLeod W, Kennedy L, McLeod K (2008) Osteoporosis health beliefs among younger and older men and women. Health Educ Behav 35:721–733CrossRefGoogle Scholar
  26. 26.
    Sedlak CA, Doheny MO, Estok PJ (2000) Osteoporosis in older men: knowledge and health beliefs. Orthop Nurs 19:38–46CrossRefGoogle Scholar
  27. 27.
    Sawka AM, Adachi JD, Papaioannou A, Thabane L, Ioannidis G, Davison KS, Olszynski WP, Brown JP, Hanley DA, Murray TM (2004) Are there differences between men and women prescribed bisphosphonate therapy in Canadian subspecialty osteoporosis practices? J Rheumatol 31:1993–1995Google Scholar
  28. 28.
    Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878–882CrossRefGoogle Scholar
  29. 29.
    Bessette L, Jean S, Davison K, Roy S, Ste-Marie L-G, Brown J (2009) Factors influencing the treatment of osteoporosis following fragility fracture. Osteoporos Int 20:1911–1919CrossRefGoogle Scholar
  30. 30.
    Kuijpers MA, Van Marum RJ, Egberts AC, Jansen PA (2008) Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 65:130–133CrossRefGoogle Scholar
  31. 31.
    Wilk A, Sajjan S, Modi A, Fan C-P, Mavros P (2014) Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA. Osteoporos Int 25:2777–2786CrossRefGoogle Scholar

Copyright information

© The Japanese Society for Bone and Mineral Research and Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  • Youn Jung
    • 1
  • Yeonhee Ko
    • 2
  • Ha Young Kim
    • 3
  • Yong Chan Ha
    • 4
  • Young-Kyun Lee
    • 5
  • Tae-Young Kim
    • 6
  • Dong-soo Choo
    • 7
  • Sunmee Jang
    • 8
    Email author
  1. 1.Korea Institute for Health and Social AffairsSejongRepublic of Korea
  2. 2.Gachon University Gil Medical CenterIncheonSouth Korea
  3. 3.Department of Internal MedicineWonkwang University Sanbon HospitalGunpoSouth Korea
  4. 4.Department of Orthopaedic SurgeryChung-Ang University College of MedicineSeoulSouth Korea
  5. 5.Department of Orthopaedic SurgerySeoul National University Bundang HospitalSeongnamSouth Korea
  6. 6.Department of Orthopaedic Surgery, Konkuk University Hospital, School of MedicineKonkuk UniversitySeoulSouth Korea
  7. 7.Big Data Steering DepartmentNational Health Insurance ServiceWonjuSouth Korea
  8. 8.College of Pharmacy and Gachon Institute of Pharmaceutical SciencesGachon UniversityIncheonSouth Korea

Personalised recommendations